8-K 1 f17948e8vk.htm FORM 8-K e8vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
Current Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
MARCH 1, 2006
 
Date of Report (Date of earliest event reported)
CEPHEID
 
(Exact name of Registrant as specified in its charter)
         
California   000-30755   77-0441625
         
(State of incorporation)   (Commission   (I.R.S. Employer
    file number)   Identification No.)
904 Caribbean Drive
Sunnyvale, CA 94089
 
(Address of principal executive offices, including zip code)
(408) 541-4191
 
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

TABLE OF CONTENTS

ITEM 8.01. OTHER EVENTS.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
SIGNATURES
EXHIBIT INDEX
EXHIBIT 99.01

Table of Contents

ITEM 8.01. OTHER EVENTS.
On March 1, 2006, Cepheid issued a press release announcing that it had submitted its Xpert GBSTM test for Group B Streptococcus (GBS) for use on the GeneXpert System to the U.S. Food & Drug Administration for regulatory clearance. A copy of the press release is attached as Exhibit 99.01 to this current report on Form 8-K and is incorporated by reference herein.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
  (d)   Exhibits.
     
Number   Description
99.01  
Press release dated March 1, 2006

 

Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
    CEPHEID
 
        
Date: March 1, 2006
        
 
        
 
  By:   /s/ JOHN R. SLUIS
 
       
 
  Name:   John R. Sluis
 
  Title:   Senior Vice President, Finance, and
 
      Chief Financial Officer

 

Table of Contents

EXHIBIT INDEX
     
Number   Description
99.01  
Press Release dated March 1, 2006.